News

A bacterial species found in the human stomach and intestines may have important implications for treating colorectal cancer.

A new marker that could be used to diagnose fatal breast cancer up to one year ahead of current methods has been identified in a study led by UCL.

Second edition of accelerator unveils seed funding winners.

Researchers from Nagoya University have developed a nanowire device able to detect microscopic levels of urinary markers potentially implicated in cancer.

Hokkaido University researchers have uncovered a cellular protein that stabilizes a tumor promoting signaling pathway, suggesting a new target to treat prostate cancer.

Researchers found that patients with breast, gastric or lung cancers survived longer when they had higher levels of Bmal1 protein.

Chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used to treat an unrelated condition, new research shows.

Use your smartphone to check how clean the air is, whether food is fresh or a lump is malignant. This has all come a step closer thanks to a new spectrometer that is so small it can be incorporated easily and cheaply in a mobile phone. The little sensor is just as precise as the normal tabletop models used in scientific labs.

Now a new potential drug carrier to treat gynecological conditions has joined the fleet: sperm. Scientists report that they have exploited the swimming power of sperm to ferry a cancer drug directly to a cervical tumor in lab tests.

Roche today announced the US Food and Drug Administration (FDA) has approved Perjeta® (pertuzumab), in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen), for adjuvant (after surgery) treatment of HER2-positive early breast cancer (eBC) at high risk of recurrence.